This variability in the ability to invade and migrate tumor cells across different CRC cell lines suggests that PRDX1 might predict prognosis and serve as a potential therapeutic target, regulating tumor metastasis and angiogenesis in colorectal cancer. The gene discussed is PRDX1; the disease is colorectal carcinoma.